Optimization of the expression of the main protease from SARS-CoV-2

Protein Expr Purif. 2023 Mar:203:106208. doi: 10.1016/j.pep.2022.106208. Epub 2022 Nov 18.

Abstract

The main protease (Mpro) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) plays a vital role in viral replication. To study the function of Mpro and screen inhibitors targeting Mpro, it is necessary to prepare high-purity and high-activity Mpro. In this study, four types of SARS-CoV-2 Mpros containing different termini were prepared, and their activities were determined successfully. The results showed that the activity of wild-type (WT) Mpro was the highest, and the additional residues at the N-terminus but not at the C-terminus had a major effect on the enzyme activity. To explain this, the alignment of structures of different forms of Mpro was determined, and the additional residues at the N-terminus were found to interfere with the formation of the substrate binding pocket. This study confirms the importance of the natural N-terminus to the activity of Mpro and suggests that WT-GPH6 (Mpro with eight additional residues at the C-terminus) can be used as a substitute for authentic Mpro to screen inhibitors. In short, this study provides a reference for the expression and purification of new coronaviruses confronted in the future.

Keywords: Additional residues; Enzyme activity; Kinetic parameters; Main protease; SARS-CoV-2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / chemistry
  • COVID-19* / genetics
  • Cysteine Endopeptidases / chemistry
  • Humans
  • Molecular Docking Simulation
  • Protease Inhibitors / pharmacology
  • SARS-CoV-2* / genetics
  • SARS-CoV-2* / metabolism

Substances

  • Cysteine Endopeptidases
  • Protease Inhibitors
  • Antiviral Agents